Development of an IL-22 based immunocytokine as a novel therapeutic approach in type 2 diabetes (2018–2019)

Grant type:
Diabetes Australia Research Trust
Researchers:
  • Honorary Research Fellow
    Mater Research Institute-UQ
    Faculty of Medicine
Funded by:
Diabetes Australia Research Trust